Publication | Closed Access
Reteplase versus Alteplase for Acute Ischemic Stroke
77
Citations
26
References
2024
Year
Among patients with ischemic stroke within 4.5 hours after symptom onset, reteplase was more likely to result in an excellent functional outcome than alteplase. (Funded by China Resources Angde Biotech Pharma and others; RAISE ClinicalTrials.gov number, NCT05295173.).
| Year | Citations | |
|---|---|---|
Page 1
Page 1